TD Cowen Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price

Globe Life (NYSE:GL) had its price target lifted by TD Cowen from $215.00 to $225.00 in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock.

GL has been the subject of a number of other research reports. Morgan Stanley boosted their price objective on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a report on Monday, July 6th. Jefferies Financial Group lifted their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. Piper Sandler boosted their price target on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Keefe, Bruyette & Woods boosted their price target on shares of Globe Life from $180.00 to $192.00 and gave the company an “outperform” rating in a report on Monday, July 13th. Finally, Truist Financial upped their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and an average price target of $187.60.

Globe Life Stock Down 0.3%

NYSE:GL opened at $183.71 on Wednesday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life has a 12-month low of $122.48 and a 12-month high of $191.55. The stock’s fifty day simple moving average is $168.37 and its 200-day simple moving average is $152.54. The firm has a market capitalization of $14.26 billion, a P/E ratio of 12.70 and a beta of 0.47.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the company posted $3.05 EPS. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities research analysts expect that Globe Life will post 15.64 earnings per share for the current year.

Globe Life Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a yield of 0.7%. Globe Life’s dividend payout ratio is presently 9.13%.

Insider Activity

In other Globe Life news, CFO Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $153.65, for a total value of $2,402,625.05. Following the sale, the chief financial officer owned 45,335 shares of the company’s stock, valued at $6,965,722.75. This trade represents a 25.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Frank M. Svoboda sold 20,000 shares of the business’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $156.68, for a total value of $3,133,600.00. Following the completion of the sale, the chief executive officer owned 54,020 shares in the company, valued at approximately $8,463,853.60. This trade represents a 27.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 124,187 shares of company stock worth $19,529,414. 2.11% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Globe Life

Hedge funds have recently made changes to their positions in the business. Hilton Head Capital Partners LLC bought a new position in shares of Globe Life in the 4th quarter valued at about $30,000. CYBER HORNET ETFs LLC bought a new stake in Globe Life during the second quarter worth about $28,000. MUFG Securities EMEA plc bought a new stake in Globe Life during the second quarter worth about $31,000. Torren Management LLC acquired a new position in Globe Life during the fourth quarter valued at approximately $37,000. Finally, AdvisorNet Financial Inc boosted its position in Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after purchasing an additional 92 shares during the last quarter. 81.61% of the stock is owned by institutional investors.

Key Headlines Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life reported second-quarter net operating income of $3.61 per share, up from $3.27 a year ago, while net income came in at $3.65 per share, showing continued year-over-year earnings growth. GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS
• Positive Sentiment: Revenue of $1.60 billion slightly beat Wall Street expectations, suggesting the company is still growing its top line despite the earnings miss. View Press Release
• Positive Sentiment: TD Cowen raised its price target on Globe Life to $225 and kept a buy rating, while JPMorgan lifted its target to $201 with an overweight rating, signaling analyst confidence in the stock’s outlook. Benzinga
• Neutral Sentiment: Globe Life updated its FY 2026 EPS guidance to $15.55-$15.95, which brackets the consensus estimate of $15.65 and suggests management is generally reaffirming its full-year outlook. GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS
• Negative Sentiment: The quarter’s EPS of $3.61 missed the analyst consensus of $3.67 by $0.06, which may limit upside for the shares despite the stronger revenue performance. View Press Release

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.